Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionBender Robert & Associates
Latest Disclosed Ownership2,819 shares
Latest Disclosed Value $ 392,884
Bender Robert & Associates ownership in GILD / Gilead Sciences, Inc.

On April 22, 2026 - Bender Robert & Associates filed a 13F-HR form disclosing ownership of 2,819 shares of Gilead Sciences, Inc. (CH:GILD) valued at $392,884 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 2,819 shares of Gilead Sciences, Inc.. This represents a change in shares of 0.00% during the quarter.

Bender Robert & Associates has a history of taking positions in derivatives of the underlying security (GILD) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CH:GILD / Gilead Sciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F GILEAD SCIENCES COM 375558103 2,819 0 0.00 393 13.29 0.0942
2026-01-29 2025-12-31 13F GILEAD SCIENCES COM 375558103 2,819 0 0.00 346 10.90 0.0719
2025-10-22 2025-09-30 13F GILEAD SCIENCES COM 375558103 2,819 -50 -1.74 313 -1.89 0.0676
2025-07-24 2025-06-30 13F GILEAD SCIENCES COM 375558103 2,869 -18 -0.62 318 -1.55 0.0710
2025-04-18 2025-03-31 13F GILEAD SCIENCES COM 375558103 2,887 -7,476 -72.14 323 -66.25 0.0817
2025-02-07 2024-12-31 13F GILEAD SCIENCES COM 375558103 10,363 -971 -8.57 957 0.74 0.2311
2024-10-30 2024-09-30 13F GILEAD SCIENCES COM 375558103 11,334 11,334 950 0.2018
2024-07-30 2024-06-30 13F GILEAD SCIENCES COM 375558103 0 -21,502 -100.00 0 -100.00
2024-04-23 2024-03-31 13F GILEAD SCIENCES COM 375558103 21,502 -3,374 -13.56 1,575 -21.84 0.3691
2024-01-31 2023-12-31 13F GILEAD SCIENCES COM 375558103 24,876 -5,262 -17.46 2,015 -10.76 0.5079
2023-10-16 2023-09-30 13F GILEAD SCIENCES COM 375558103 30,138 -890 -2.87 2,259 -5.56 0.6600
2023-07-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 31,028 -3,016 -8.86 2,391 -15.33 0.6604
2023-04-21 2023-03-31 13F GILEAD SCIENCES COM 375558103 34,044 -375 -1.09 2,825 -4.40 0.8747
2023-02-02 2022-12-31 13F GILEAD SCIENCES COM 375558103 34,419 -1,927 -5.30 2,955 31.76 1.1049
2022-10-27 2022-09-30 13F GILEAD SCIENCES COM 375558103 36,346 -1,254 -3.34 2,242 -3.53 0.8682
2022-07-19 2022-06-30 13F GILEAD SCIENCES COM 375558103 37,600 -2,107 -5.31 2,324 -1.57 0.8886
2022-04-14 2022-03-31 13F GILEAD SCIENCES COM 375558103 39,707 -7,364 -15.64 2,361 -28.19 0.6725
2022-02-07 2021-12-31 13F GILEAD SCIENCES COM 375558103 47,071 0 0.00 3,288 0.00 0.9488
2021-11-09 2021-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 47,071 -2,617 -5.27 3,288 -3.92 0.9412
2021-11-03 2021-09-30 13F GILEAD SCIENCES COM 375558103 34,204 -15,484 6,048 1.7557
2021-07-16 2021-06-30 13F GILEAD SCIENCES COM 375558103 49,688 -1,220 -2.40 3,422 4.01 0.9723
2021-04-28 2021-03-31 13F GILEAD SCIENCES COM 375558103 50,908 -89 -0.17 3,290 10.74 1.0585
2021-01-29 2020-12-31 13F GILEAD SCIENCES COM 375558103 50,997 -2,212 -4.16 2,971 -11.63 0.9454
2020-10-29 2020-09-30 13F GILEAD SCIENCES COM 375558103 53,209 -1,774 -3.23 3,362 -20.52 1.2038
2020-07-31 2020-06-30 13F GILEAD SCIENCES COM 375558103 54,983 -1,941 -3.41 4,230 -0.61 1.6721
2020-04-21 2020-03-31 13F GILEAD SCIENCES COM 375558103 56,924 -3,343 -5.55 4,256 8.68 2.2669
2020-01-31 2019-12-31 13F GILEAD SCIENCES COM 375558103 60,267 -3,953 -6.16 3,916 -3.78 1.7667
2019-10-15 2019-09-30 13F GILEAD SCIENCES COM 375558103 64,220 -1,536 -2.34 4,070 -7.50 2.0358
2019-07-30 2019-06-30 13F GILEAD SCIENCES COM 375558103 65,756 -10,796 -14.10 4,400 -11.59 2.0872
2019-04-30 2019-03-31 13F GILEAD SCIENCES COM 375558103 76,552 -13,652 -15.13 4,977 -11.79 2.4387
2019-01-24 2018-12-31 13F GILEAD SCIENCES COM 375558103 90,204 -926 -1.02 5,642 -19.81 3.2572
2018-10-17 2018-09-30 13F GILEAD SCIENCES COM 375558103 91,130 -215 -0.24 7,036 8.73 3.2000
2018-07-27 2018-06-30 13F GILEAD SCIENCES COM 375558103 91,345 -2,261 -2.42 6,471 -8.30 3.3938
2018-04-27 2018-03-31 13F GILEAD SCIENCES COM 375558103 93,606 -2,228 -2.32 7,057 2.78 3.9195
2018-01-19 2017-12-31 13F GILEAD SCIENCES COM 375558103 95,834 -208 -0.22 6,866 -11.76 3.8044
2017-10-23 2017-09-30 13F GILEAD SCIENCES COM 375558103 96,042 -329 -0.34 7,781 14.07 4.4714
2017-08-03 2017-06-30 13F GILEAD SCIENCES COM 375558103 96,371 480 0.50 6,821 4.73 4.1829
2017-05-11 2017-03-31 13F GILEAD SCIENCES COM 375558103 95,891 -1,113 -1.15 6,513 -6.23 4.1977
2017-01-26 2016-12-31 13F GILEAD SCIENCES COM 375558103 97,004 -1,883 -1.90 6,946 -11.22 4.9201
2016-10-27 2016-09-30 13F GILEAD SCIENCES COM 375558103 98,887 -1,133 -1.13 7,824 -6.23 5.1685
2016-07-22 2016-06-30 13F GILEAD SCIENCES COM 375558103 100,020 -1,477 -1.46 8,344 -10.51 5.8880
2016-04-27 2016-03-31 13F GILEAD SCIENCES COM 375558103 101,497 -2,717 -2.61 9,324 -11.58 6.3128
2016-02-03 2015-12-31 13F GILEAD SCIENCES COM 375558103 104,214 -1,092 -1.04 10,545 1.98 6.7511
2015-10-29 2015-09-30 13F GILEAD SCIENCES COM 375558103 105,306 -2,487 -2.31 10,340 -18.07 6.9969
2015-08-10 2015-06-30 13F GILEAD SCIENCES COM 375558103 107,793 -777 -0.72 12,620 18.45 7.4906
2015-04-27 2015-03-31 13F GILEAD SCIENCES COM 375558103 108,570 108,570 0.00 10,654 6.2127
2015-02-03 2014-12-31 13F GILEAD SCIENCES COM 375558103 0 -108,813 -100.00 0 -100.00
2014-11-12 2014-09-30 13F GILEAD SCIENCES COM 375558103 108,813 -886 -0.81 11,583 27.36 8.0631
2014-08-04 2014-06-30 13F GILEAD SCIENCES COM 375558103 109,699 -138 -0.13 9,095 16.86 6.4348
2014-05-07 2014-03-31 13F GILEAD SCIENCES COM 375558103 109,837 -2,681 -2.38 7,783 -7.89 5.2197
2014-01-28 2013-12-31 13F GILEAD SCIENCES COM 375558103 112,518 -2,117 -1.85 8,450 17.25 6.3495
2013-11-04 2013-09-30 13F GILEAD SCIENCES INC C COMMON 375558103 114,635 -621 -0.54 7,207 21.97 5.6477
2013-07-23 2013-06-30 13F GILEAD SCIENCES COM 375558103 115,256 115,256 5,909 5.0728
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-10-30 2024-09-30 13F GILEAD SCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-07-30 2024-06-30 13F GILEAD SCIENCES COM Put 18,713 1,284 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.